JON HOVERSLAND: Open Payments
NPI 1699822320 · MUNCIE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 34 payments from 20 companies in 2025. Trend: 2023 $442 · 2024 $356 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 4 | $62 |
| ABBVIE INC. | 3 | $46 |
| Biogen, Inc. | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Exact Sciences Corporation | 2 | $35 |
| Astellas Pharma US Inc | 2 | $35 |
| CooperSurgical, Inc. | 2 | $35 |
| Indivior Inc. | 2 | $33 |
| Novo Nordisk Inc | 2 | $30 |
Products named: REXULTI, Kerendia, VRAYLAR, ZURZUVAE, CAPLYTA, Cologuard Collection Kit, Veozah, SUBLOCADE.
Industry payments across IN — which companies pay providers there.
